We are live on ! Find out more
CVS icon

CVS Health

1,130 hedge funds and large institutions have $58.3B invested in CVS Health in 2013 Q3 according to their latest regulatory filings, with 86 funds opening new positions, 440 increasing their positions, 470 reducing their positions, and 50 closing their positions.

New
Increased
Maintained
Reduced
Closed

72% more first-time investments, than exits

New positions opened: 86 | Existing positions closed: 50

2% more funds holding

Funds holding: 1,1071,130 (+23)

2% less capital invested

Capital invested by funds: $59.6B → $58.3B (-$1.33B)

6% less repeat investments, than reductions

Existing positions increased: 440 | Existing positions reduced: 470

1.62% less ownership

Funds ownership: 84.59%82.97% (-1.6%)

18% less call options, than puts

Call options by funds: $227M | Put options by funds: $276M

23% less funds holding in top 10

Funds holding in top 10: 10883 (-25)

Holders
1,130
Holders Change
+23
Holders Change %
+2.08%
% of All Funds
36.63%
Holding in Top 10
83
Holding in Top 10 Change
-25
Holding in Top 10 Change %
-23.15%
% of All Funds
2.69%
New
86
Increased
440
Reduced
470
Closed
50
Calls
$227M
Puts
$276M
Net Calls
-$48.8M
Net Calls Change
-$12.9M
Name Holding Trade Value Shares
Change
Change in
Stake
CCMG
626
Clark Capital Management Group
Pennsylvania
$2.44M -$85.4K -1,434 -3%
ECM
627
ETrade Capital Management
Virginia
$2.41M +$543K +9,113 +27%
IPRC
628
Indices-Pac Research Corporation
New Jersey
$2.39M +$1.32M +22,172 +111%
Creative Planning
629
Creative Planning
Kansas
$2.36M +$356K +5,980 +17%
TBA
630
Train Babcock Advisors
New York
$2.35M -$5.96K -100 -0.2%
SCM
631
Sterneck Capital Management
Missouri
$2.34M -$279K -4,689 -10%
PCMI
632
Paradigm Capital Management Inc
New York
$2.34M -$427K -7,160 -15%
MERSOM
633
Municipal Employees' Retirement System of Michigan
Michigan
$2.33M +$2.44M +41,000 New
OSNBOA
634
Old Second National Bank of Aurora
Illinois
$2.32M +$2.41M +40,435 +9,514%
CFM
635
Country Fund Management
Illinois
$2.32M -$2.16M -36,300 -47%
BMO
636
Beck Mack & Oliver
New York
$2.3M -$11.9K -200 -0.5%
TCOO
637
Trust Company of Oklahoma
Oklahoma
$2.28M -$14K -235 -0.6%
Bank of Nova Scotia
638
Bank of Nova Scotia
Ontario, Canada
$2.28M +$1.29M +21,616 +117%
AW
639
ACG Wealth
Georgia
$2.28M -$164K -2,747 -6%
KIA
640
KCM Investment Advisors
California
$2.26M -$115K -1,927 -5%
SSI
641
Scott & Selber Inc
Texas
$2.26M -$23.8K -400 -1%
HIM
642
Hermes Investment Management
United Kingdom
$2.25M -$113K -1,900 -5%
BIM
643
BRC Investment Management
Colorado
$2.22M -$15.1M -253,340 -87%
SNT
644
Security National Trust
West Virginia
$2.21M +$106K +1,785 +5%
RW
645
Rand Wealth
Maryland
$2.19M +$232K +3,900 +11%
BFO
646
Boston Family Office
Massachusetts
$2.19M -$60.3K -1,012 -3%
CA
647
Cullinan Associates
Kentucky
$2.18M +$179K +3,000 +8%
Walleye Trading
648
Walleye Trading
New York
$2.16M +$2.27M +38,138 New
VanEck Associates
649
VanEck Associates
New York
$2.16M +$392K +6,572 +21%
HCMT
650
Highland Capital Management (Tennessee)
Tennessee
$2.12M +$2.23M +37,386 New

CVS Hedge Fund Activity: Q3 2013 in Review

1,130 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in CVS Health (CVS) for Q3 2013, worth a combined $58.3B — down 2.2% from $59.6B a quarter earlier.

Buyers outnumbered sellers: 86 funds opened new CVS positions and 50 closed out — a net gain of 36 holders — while 440 added to existing stakes and 470 trimmed.

The largest buyer was abrdn Investment Management, adding an estimated $166M. The largest seller was Fidelity Investments, cutting an estimated $270M.

  • 1,130 institutional investors held CVS Health (CVS) as of Q3 2013, up from 1,107 in Q2 2013.
  • Funds reported $58.3B of CVS Health stock for Q3 2013, down 2.2% quarter-over-quarter.
  • 86 funds opened new CVS Health positions in Q3 2013 and 50 closed out, a net change of +36 holders.
  • The largest CVS Health buyer in Q3 2013 was abrdn Investment Management, an estimated $166M added.
  • The largest CVS Health seller in Q3 2013 was Fidelity Investments, an estimated $270M sold.

Based on aggregated 13F filings for Q3 2013.